SynLethDB: Synthetic lethality database toward discovery of selective and sensitive anticancer drug targets

Nucleic Acids Research

Volumn 44, Issue D1, 2016, Pages D1011-D1017

  Guo, Jing ^a   Liu, Hui ^a,b   Zheng, Jie ^a,c  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^b CHANGZHOU UNIVERSITY   (China)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL; COMPUTER INTERFACE; DATA ANALYSIS; DRUG SENSITIVITY; GENE EXPRESSION; GENE INTERACTION; GENETIC DATABASE; HUMAN; MEDICAL RESEARCH; MOLECULAR GENETICS; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; SYNLETH DATABASE; SYNTHETIC LETHALITY; ANIMAL; CELL DEATH; DRUG DATABASE; DRUG DEVELOPMENT; MOUSE; MUTATION; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR GENE;

ANTINEOPLASTIC AGENT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; DATA INTERPRETATION, STATISTICAL; DATABASES, PHARMACEUTICAL; DRUG DISCOVERY; GENES, NEOPLASM; HUMANS; MICE; MUTATION; RNA INTERFERENCE;

EID: 84976871880     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv1108     Document Type: Article

References (49)

1. Boone, C., Bussey, H. and Andrews, B. J. (2007) Exploring genetic interactions and networks with yeast. Nat. Rev. Genet., 8, 437-449.
2. Nijman, S. M. (2011) Synthetic lethality: general principles, utility and detection using genetic screens in human cells. FEBS Lett., 585, 1-6.
3. McLornan, D. P., List, A. and Mufti, G. J. (2014) Applying synthetic lethality for the selective targeting of cancer. N. Engl. J. Med., 371, 1725-1735.
4. Kaelin, W. G. Jr (2009) Synthetic lethality: a framework for the development of wiser cancer therapeutics. Genome Med., 1, 99.
5. Iglehart, J. D. and Silver, D. P. (2009) Synthetic lethality-a new direction in cancer-drug development. N. Engl. J. Med., 361, 189-191.
6. Bridges, C. B. (1922) The origin of variation. Am. Nat., 56, 51-63.
7. Costanzo, M., Baryshnikova, A., Bellay, J., Kim, Y., Spear, E. D., Sevier, C. S., Ding, H., Koh, J. L., Toufighi, K., Mostafavi, S. et al. (2010) The genetic landscape of a cell. Science, 327, 425-431.
8. Hillenmeyer, M. E., Fung, E., Wildenhain, J., Pierce, S. E., Hoon, S., Lee, W., Proctor, M., Onge, R. P. S., Tyers, M., Koller, D. et al. (2008) The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science, 320, 362-365.
9. Whitehurst, A. W., Bodemann, B. O., Cardenas, J., Ferguson, D., Girard, L., Peyton, M., Minna, J. D., Michnoff, C., Hao, W., Roth, M. G. et al. (2007) Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature, 446, 815-819.
10. Turner, N. C., Lord, C. J., Iorns, E., Brough, R., Swift, S., Elliott, R., Rayter, S., Tutt, A. N., Ashworth, A. et al. (2008) A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. EMBO J., 27, 1368-1377.
11. Luo, J., Emanuele, M. J., Li, D., Creighton, C. J., Schlabach, M. R., Westbrook, T. F., Wong, K.-K. and Elledge, S. J. (2009) A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell, 137, 835-848.
12. Deshpande, R., Asiedu, M. K., Klebig, M., Sutor, S., Kuzmin, E., Nelson, J., Piotrowski, J., Shin, S. H., Yoshida, M., Costanzo, M. et al. (2013) A comparative genomic approach for identifying synthetic lethal interactions in human cancer. Cancer Res., 73, 6128-6136.
13. Jerby-Arnon, L., Pfetzer, N., Waldman, Y. Y., McGarry, L., James, D., Shanks, E., Seashore-Ludlow, B., Weinstock, A., Geiger, T., Clemons, P. A. et al. (2014) Predicting cancer-specific vulnerability via data-driven detection of synthetic lethality. Cell, 158, 1199-1209.
14. Wu, M., Li, X.-J., Zhang, F., Li, X.-L., Kwoh, C.-K. and Zheng, J. (2014) In silico prediction of synthetic lethality by meta-analysis of genetic interactions, functions, and pathways in yeast and human cancer. Cancer Inform., 13, 71-80.
15. Lu, X., Kensche, P. R., Huynen, M. A. and Notebaart, R. A. (2013) Genome evolution predicts genetic interactions in protein complexes and reveals cancer drug targets. Nat. Commun., 4, 2124.
16. Folger, O., Jerby, L., Frezza, C., Gottlieb, E., Ruppin, E. and Shlomi, T. (2011) Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol., 7, 501.
17. Zhang, F., Wu, M., Li, X.-J., Li, X.-L., Kwoh, C.-K. and Zheng, J. (2015) Predicting essential genes and synthetic lethality via influence propagation in signaling pathways of cancer cell fates. J. Bioinform. Comput. Biol., 13.
18. Li, X.-J., Mishra, S. K., Wu, M., Zhang, F. and Zheng, J. (2014) Syn-Lethality: an integrative knowledge base of synthetic lethality towards discovery of selective anticancer therapies. BioMed Res. Int., 2014, 196034.
19. Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B. and Hassanali, M. (2008) DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res., 36, D901-D906.
20. Chatr-aryamontri, A., Breitkreutz, B.-J., Oughtred, R., Boucher, L., Heinicke, S., Chen, D., Stark, C., Breitkreutz, A., Kolas, N., O'Donnell, L. et al. (2015) The BioGRID interaction database: 2015 update. Nucleic Acids Res., 43, D470-D478.
21. Schmidt, E. E., Pelz, O., Buhlmann, S., Kerr, G., Horn, T. and Boutros, M. (2013) GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes. Nucleic Acids Res., 41, D1021-D1026.
22. Fontaine, J. F., Barbosa-Silva, A., Schaefer, M., Huska, M. R., Muro, E. M. and Andrade-Navarro, M. A. (2009) MedlineRanker: flexible ranking of biomedical literature. Nucleic Acids Res., 37, W141-W146.
23. Barbosa-Silva, A., Fontaine, J.-F., Donnard, E. R., Stussi, F., Ortega, J. M. and Andrade-Navarro, M. A. (2011) PESCADOR, a web-based tool to assist text-mining of biointeractions extracted from PubMed queries. BMC Bioinformatics, 12, 435.
24. Meluh, P. B., Pan, X., Yuan, D. S., Tiffany, C., Chen, O., Sookhai-Mahadeo, S., Wang, X., Peyser, B. D., Irizarry, R., Spencer, F. A. et al. (2008) Analysis of genetic interactions on a genome-wide scale in budding yeast: diploid-based synthetic lethality analysis by microarray. Methods Mol. Biol., 416, 221-247.
25. Cao, M., Pietras, C. M., Feng, X., Doroschak, K. J., Schaffner, T., Park, J., Zhang, H., Cowen, L. J. and Hescott, B. J. (2014) New directions for diffusion-based network prediction of protein function: incorporating pathways with confidence. Bioinformatics, 30, i219-i227.
26. Kuhn, M., Szklarczyk, D., Pletscher-Frankild, S., Blicher, T. H., vonMering, C., Jensen, L. J. and Bork, P. (2014) STITCH 4: integration of protein-chemical interactions with user data. Nucleic Acids Res., 42, D401-D407.
27. Veres, D. V., Gyurkó, D. M., Thaler, B., Szalay, K. Z., Fazekas, D., Korcsmáros, T. and Csermely, P. (2015) ComPPI: a cellular compartment-specific database for protein-protein interaction network analysis. Nucleic Acids Res., 43, D485-D493.
28. Tang, J., Szwajda, A., Shakyawar, S., Xu, T., Hintsanen, P., Wennerberg, K. and Aittokallio, T. (2014) Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis. J. Chem. Inf. Model., 54, 735-743.
29. Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K. and Zarrinkar, P. P. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat. Biotechnol., 29, 1046-1051.
30. Metz, J. T., Johnson, E. F., Soni, N. B., Merta, P. J., Kifle, L. and Hajduk, P. J. (2011) Navigating the kinome. Nat. Chem. Biol., 7, 200-202.
31. Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H. and Peterson, J. R. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol., 29, 1039-1045.
32. Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B. et al. (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucl. Acids Res., 40, D1100-D1107.
33. Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D. et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 483, 603-607.
34. Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R. et al. (2013) Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res., 41, D955-D961.
35. Shoemaker, R. H. (2006) The NCI60 human tumour cell line anticancer drug screen. Nat. Rev. Cancer, 6, 813-823.
36. Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A. et al. (2011) COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res., 39, D945-D950.
37. UniProt Consortium. (2014) UniProt: a hub for protein information. Nucleic Acids Res., 43, D204-D212.
38. Flicek, P., Amode, M. R., Barrell, D., Beal, K., Billis, K., Brent, S., Carvalho-Silva, D., Clapham, P., Coates, G., Fitzgerald, S. et al. (2014) Ensembl 2014. Nucleic Acids Res., 42, D749-D755.
39. Benson, D. A., Clark, K., Karsch-Mizrachi, I., Lipman, D. J., Ostell, J. and Sayers, E. W. (2015) GenBank. Nucleic Acids Res., 43, D30-D35.
40. Sonnhammer, E. L. and Ostlund, G. (2009) InParanoid 8: orthology analysis between 273 proteomes, mostly eukaryotic. Nucleic Acids Res., 43, D234-D239.
41. Vilella, A. J., Severin, J., Ureta-Vidal, A., Heng, L., Durbin, R. and Birney, E. (2009) EnsemblCompara GeneTrees: complete, duplication-aware phylogenetic trees in vertebrates. Genome Res., 19, 327-335.
42. Huerta-Cepas, J., Capella-Gutiérrez, S., Pryszcz, L. P., Marcet-Houben, M. and Gabaldón, T. (2014) PhylomeDB v4: zooming into the plurality of evolutionary histories of a genome. Nucleic Acids Res., 42, D897-D902.
43. Shin, C. J., Davis, M. J. and Ragan, M. A. (2009) Towards the mammalian interactome: inference of a core mammalian interaction set in mouse. Proteomics, 9, 5256-5266.
44. Altenhoff, A. M. and Dessimoz, C. (2009) Phylogenetic and functional assessment of orthologs inference projects and methods. PLoS Comput. Biol., 5, e1000262.
45. Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J. and Bryant, S. H. (2009) PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res., 37, W623-W633.
46. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M. and Hirakawa, M. (2010) KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res., 38, D355-D360.
47. D'Eustachio, P. (2011) Reactome knowledgebase of human biological pathways and processes. Methods Mol. Biol., 694, 49-61.
48. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T. et al. (2000) Gene ontology: tool for the unification of biology. Nat. Genet., 25, 25-29.
49. Burrell, R. A., McGranahan, N., Bartek, J. and Swanton, C. (2013) The causes and consequences of genetic heterogeneity in cancer evolution. Nature, 501, 338-345.